This report contains market size and forecasts of Fostamatinib in global, including the following market information:
- Global Fostamatinib Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Fostamatinib Market Sales, 2018-2023, 2023-2030, (K Bottles)
- Global top five Fostamatinib companies in 2022 (%)
The global Fostamatinib market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Tavalisse Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Fostamatinib include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada and AstraZeneca, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fostamatinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fostamatinib Market, by Brand, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Brand, 2022 (%)
Global Fostamatinib Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Application, 2022 (%)
- Idiopathic (Immune) Thrombocytopenic Purpura
- Waldenstrm's Macroglobulinemia
- Autoimmune Haemolytic Anaemia
- Other
Global Fostamatinib Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Fostamatinib revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Fostamatinib revenues share in global market, 2022 (%)
- Key companies Fostamatinib sales in global market, 2018-2023 (Estimated), (K Bottles)
- Key companies Fostamatinib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Rigel Pharmaceuticals, Inc
- Kissei Pharmaceutical Co., Ltd
- Grifols
- JW Pharmaceutical Corporation
- Medison Pharma Canada
- AstraZeneca
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fostamatinib Market Definition
1.2 Market Segments
1.2.1 Market by Brand
1.2.2 Market by Application
1.3 Global Fostamatinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fostamatinib Overall Market Size
2.1 Global Fostamatinib Market Size: 2022 VS 2030
2.2 Global Fostamatinib Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Fostamatinib Sales: 2018-2030
3 Company Landscape
3.1 Top Fostamatinib Players in Global Market
3.2 Top Global Fostamatinib Companies Ranked by Revenue
3.3 Global Fostamatinib Revenue by Companies
3.4 Global Fostamatinib Sales by Companies
3.5 Global Fostamatinib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fostamatinib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fostamatinib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fostamatinib Players in Global Market
3.8.1 List of Global Tier 1 Fostamatinib Companies
3.8.2 List of Global Tier 2 and Tier 3 Fostamatinib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Brand - Global Fostamatinib Market Size Markets, 2022 & 2030
4.1.2 Tavalisse
4.1.3 Tavlesse
4.2 By Brand - Global Fostamatinib Revenue & Forecasts
4.2.1 By Brand - Global Fostamatinib Revenue, 2018-2023
4.2.2 By Brand - Global Fostamatinib Revenue, 2023-2030
4.2.3 By Brand - Global Fostamatinib Revenue Market Share, 2018-2030
4.3 By Brand - Global Fostamatinib Sales & Forecasts
4.3.1 By Brand - Global Fostamatinib Sales, 2018-2023
4.3.2 By Brand - Global Fostamatinib Sales, 2023-2030
4.3.3 By Brand - Global Fostamatinib Sales Market Share, 2018-2030
4.4 By Brand - Global Fostamatinib Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Fostamatinib Market Size, 2022 & 2030
5.1.2 Idiopathic (Immune) Thrombocytopenic Purpura
5.1.3 Waldenstr?m's Macroglobulinemia
5.1.4 Autoimmune Haemolytic Anaemia
5.1.5 Other
5.2 By Application - Global Fostamatinib Revenue & Forecasts
5.2.1 By Application - Global Fostamatinib Revenue, 2018-2023
5.2.2 By Application - Global Fostamatinib Revenue, 2023-2030
5.2.3 By Application - Global Fostamatinib Revenue Market Share, 2018-2030
5.3 By Application - Global Fostamatinib Sales & Forecasts
5.3.1 By Application - Global Fostamatinib Sales, 2018-2023
5.3.2 By Application - Global Fostamatinib Sales, 2023-2030
5.3.3 By Application - Global Fostamatinib Sales Market Share, 2018-2030
5.4 By Application - Global Fostamatinib Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Fostamatinib Market Size, 2022 & 2030
6.2 By Region - Global Fostamatinib Revenue & Forecasts
6.2.1 By Region - Global Fostamatinib Revenue, 2018-2023
6.2.2 By Region - Global Fostamatinib Revenue, 2023-2030
6.2.3 By Region - Global Fostamatinib Revenue Market Share, 2018-2030
6.3 By Region - Global Fostamatinib Sales & Forecasts
6.3.1 By Region - Global Fostamatinib Sales, 2018-2023
6.3.2 By Region - Global Fostamatinib Sales, 2023-2030
6.3.3 By Region - Global Fostamatinib Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Fostamatinib Revenue, 2018-2030
6.4.2 By Country - North America Fostamatinib Sales, 2018-2030
6.4.3 US Fostamatinib Market Size, 2018-2030
6.4.4 Canada Fostamatinib Market Size, 2018-2030
6.4.5 Mexico Fostamatinib Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Fostamatinib Revenue, 2018-2030
6.5.2 By Country - Europe Fostamatinib Sales, 2018-2030
6.5.3 Germany Fostamatinib Market Size, 2018-2030
6.5.4 France Fostamatinib Market Size, 2018-2030
6.5.5 U.K. Fostamatinib Market Size, 2018-2030
6.5.6 Italy Fostamatinib Market Size, 2018-2030
6.5.7 Russia Fostamatinib Market Size, 2018-2030
6.5.8 Nordic Countries Fostamatinib Market Size, 2018-2030
6.5.9 Benelux Fostamatinib Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Fostamatinib Revenue, 2018-2030
6.6.2 By Region - Asia Fostamatinib Sales, 2018-2030
6.6.3 China Fostamatinib Market Size, 2018-2030
6.6.4 Japan Fostamatinib Market Size, 2018-2030
6.6.5 South Korea Fostamatinib Market Size, 2018-2030
6.6.6 Southeast Asia Fostamatinib Market Size, 2018-2030
6.6.7 India Fostamatinib Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Fostamatinib Revenue, 2018-2030
6.7.2 By Country - South America Fostamatinib Sales, 2018-2030
6.7.3 Brazil Fostamatinib Market Size, 2018-2030
6.7.4 Argentina Fostamatinib Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fostamatinib Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Fostamatinib Sales, 2018-2030
6.8.3 Turkey Fostamatinib Market Size, 2018-2030
6.8.4 Israel Fostamatinib Market Size, 2018-2030
6.8.5 Saudi Arabia Fostamatinib Market Size, 2018-2030
6.8.6 UAE Fostamatinib Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Rigel Pharmaceuticals, Inc
7.1.1 Rigel Pharmaceuticals, Inc Corporate Summary
7.1.2 Rigel Pharmaceuticals, Inc Business Overview
7.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Major Product Offerings
7.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Sales and Revenue in Global (2018-2023)
7.1.5 Rigel Pharmaceuticals, Inc Key News
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Corporate Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News
7.3 Grifols
7.3.1 Grifols Corporate Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Fostamatinib Major Product Offerings
7.3.4 Grifols Fostamatinib Sales and Revenue in Global (2018-2023)
7.3.5 Grifols Key News
7.4 JW Pharmaceutical Corporation
7.4.1 JW Pharmaceutical Corporation Corporate Summary
7.4.2 JW Pharmaceutical Corporation Business Overview
7.4.3 JW Pharmaceutical Corporation Fostamatinib Major Product Offerings
7.4.4 JW Pharmaceutical Corporation Fostamatinib Sales and Revenue in Global (2018-2023)
7.4.5 JW Pharmaceutical Corporation Key News
7.5 Medison Pharma Canada
7.5.1 Medison Pharma Canada Corporate Summary
7.5.2 Medison Pharma Canada Business Overview
7.5.3 Medison Pharma Canada Fostamatinib Major Product Offerings
7.5.4 Medison Pharma Canada Fostamatinib Sales and Revenue in Global (2018-2023)
7.5.5 Medison Pharma Canada Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Fostamatinib Major Product Offerings
7.6.4 AstraZeneca Fostamatinib Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News
8 Global Fostamatinib Production Capacity, Analysis
8.1 Global Fostamatinib Production Capacity, 2018-2030
8.2 Fostamatinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Fostamatinib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fostamatinib Supply Chain Analysis
10.1 Fostamatinib Industry Value Chain
10.2 Fostamatinib Upstream Market
10.3 Fostamatinib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fostamatinib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Fostamatinib in Global Market
Table 2. Top Fostamatinib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fostamatinib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fostamatinib Revenue Share by Companies, 2018-2023
Table 5. Global Fostamatinib Sales by Companies, (K Bottles), 2018-2023
Table 6. Global Fostamatinib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fostamatinib Price (2018-2023) & (US$/Bottle)
Table 8. Global Manufacturers Fostamatinib Product Type
Table 9. List of Global Tier 1 Fostamatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fostamatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Brand ? Global Fostamatinib Revenue, (US$, Mn), 2022 & 2030
Table 12. By Brand - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 13. By Brand - Global Fostamatinib Revenue (US$, Mn), 2023-2030
Table 14. By Brand - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 15. By Brand - Global Fostamatinib Sales (K Bottles), 2023-2030
Table 16. By Application ? Global Fostamatinib Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fostamatinib Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 20. By Application - Global Fostamatinib Sales (K Bottles), 2023-2030
Table 21. By Region ? Global Fostamatinib Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fostamatinib Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 25. By Region - Global Fostamatinib Sales (K Bottles), 2023-2030
Table 26. By Country - North America Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fostamatinib Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Fostamatinib Sales, (K Bottles), 2018-2023
Table 29. By Country - North America Fostamatinib Sales, (K Bottles), 2023-2030
Table 30. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Fostamatinib Sales, (K Bottles), 2018-2023
Table 33. By Country - Europe Fostamatinib Sales, (K Bottles), 2023-2030
Table 34. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Fostamatinib Sales, (K Bottles), 2018-2023
Table 37. By Region - Asia Fostamatinib Sales, (K Bottles), 2023-2030
Table 38. By Country - South America Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fostamatinib Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Fostamatinib Sales, (K Bottles), 2018-2023
Table 41. By Country - South America Fostamatinib Sales, (K Bottles), 2023-2030
Table 42. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2018-2023
Table 45. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2023-2030
Table 46. Rigel Pharmaceuticals, Inc Corporate Summary
Table 47. Rigel Pharmaceuticals, Inc Fostamatinib Product Offerings
Table 48. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 49. Kissei Pharmaceutical Co., Ltd Corporate Summary
Table 50. Kissei Pharmaceutical Co., Ltd Fostamatinib Product Offerings
Table 51. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 52. Grifols Corporate Summary
Table 53. Grifols Fostamatinib Product Offerings
Table 54. Grifols Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 55. JW Pharmaceutical Corporation Corporate Summary
Table 56. JW Pharmaceutical Corporation Fostamatinib Product Offerings
Table 57. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 58. Medison Pharma Canada Corporate Summary
Table 59. Medison Pharma Canada Fostamatinib Product Offerings
Table 60. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Fostamatinib Product Offerings
Table 63. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 64. Fostamatinib Production Capacity (K Bottles) of Key Manufacturers in Global Market, 2020-2023 (K Bottles)
Table 65. Global Fostamatinib Capacity Market Share of Key Manufacturers, 2020-2023
Table 66. Global Fostamatinib Production by Region, 2018-2023 (K Bottles)
Table 67. Global Fostamatinib Production by Region, 2023-2030 (K Bottles)
Table 68. Fostamatinib Market Opportunities & Trends in Global Market
Table 69. Fostamatinib Market Drivers in Global Market
Table 70. Fostamatinib Market Restraints in Global Market
Table 71. Fostamatinib Raw Materials
Table 72. Fostamatinib Raw Materials Suppliers in Global Market
Table 73. Typical Fostamatinib Downstream
Table 74. Fostamatinib Downstream Clients in Global Market
Table 75. Fostamatinib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fostamatinib Segment by Brand
Figure 2. Fostamatinib Segment by Application
Figure 3. Global Fostamatinib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fostamatinib Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Fostamatinib Revenue, 2018-2030 (US$, Mn)
Figure 7. Fostamatinib Sales in Global Market: 2018-2030 (K Bottles)
Figure 8. The Top 3 and 5 Players Market Share by Fostamatinib Revenue in 2022
Figure 9. By Brand - Global Fostamatinib Sales Market Share, 2018-2030
Figure 10. By Brand - Global Fostamatinib Revenue Market Share, 2018-2030
Figure 11. By Brand - Global Fostamatinib Price (US$/Bottle), 2018-2030
Figure 12. By Application - Global Fostamatinib Sales Market Share, 2018-2030
Figure 13. By Application - Global Fostamatinib Revenue Market Share, 2018-2030
Figure 14. By Application - Global Fostamatinib Price (US$/Bottle), 2018-2030
Figure 15. By Region - Global Fostamatinib Sales Market Share, 2018-2030
Figure 16. By Region - Global Fostamatinib Revenue Market Share, 2018-2030
Figure 17. By Country - North America Fostamatinib Revenue Market Share, 2018-2030
Figure 18. By Country - North America Fostamatinib Sales Market Share, 2018-2030
Figure 19. US Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Fostamatinib Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Fostamatinib Sales Market Share, 2018-2030
Figure 24. Germany Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 25. France Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Fostamatinib Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Fostamatinib Sales Market Share, 2018-2030
Figure 33. China Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 37. India Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Fostamatinib Revenue Market Share, 2018-2030
Figure 39. By Country - South America Fostamatinib Sales Market Share, 2018-2030
Figure 40. Brazil Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Fostamatinib Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Fostamatinib Sales Market Share, 2018-2030
Figure 44. Turkey Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Fostamatinib Revenue, (US$, Mn), 2018-2030
Figure 48. Global Fostamatinib Production Capacity (K Bottles), 2018-2030
Figure 49. The Percentage of Production Fostamatinib by Region, 2022 VS 2030
Figure 50. Fostamatinib Industry Value Chain
Figure 51. Marketing Channels
